ClinicalTrials.Veeva

Menu

The Effect of Fascia Iliaca Compartment Block (FICB) on QoR-15 Score in Partial Hip Arthroplasty Surgery

B

Başakşehir Çam & Sakura City Hospital

Status

Completed

Conditions

Fracture of Hip
Anesthesia, Local
QoR-15
Post Operative Pain

Treatments

Drug: Bupivacaine-fentanyl
Drug: Bupivacain (Postoperative)
Drug: Bupivacain (preoperative)

Study type

Interventional

Funder types

Other

Identifiers

NCT05965544
e.mendes - 2
KAEK/2023.06.259 (Other Identifier)

Details and patient eligibility

About

It reduces pain scores in patients with block and improves the quality of recovery in the postoperative period. In patients who will undergo spinal anesthesia, it will be questioned whether the application of the block before or after surgery makes a difference in the quality of recovery.

Full description

American Society of Anesthesiologists (ASA) physical status I-III patients who are planned for partial hip arthroplasty will be studied in patients over 65 years of age. The patients will be equally randomized into two groups using a computer-generated random number table. In the preoperative period, according to whether FIBP was before or after spinal anesthesia, it will be named as a separate group as Group PreS (Pre-Spinal) and Group PostS (Post-Spinal). The patient will be placed in the lateral decubitus position with the fractured side up. After the spinal anesthesia method was provided with aseptic conditions, 10 mg 0.5% isobaric bupivacaine + 20 mcg Fentanyl injection will be applied using a 26 Gauge pencil point needle through the L3-L4 or L4-L5 intervertebral space. After the patients are in the supine position and aseptic conditions are provided, the fascia on the Iliacus muscle will be determined with the help of an 8-12 MHz linear probe, and the block will be applied with the in-plane technique. During the block, patients will routinely administer 0.2% bupivacaine concentration of 0.5 mL/kg. Demographic data, operation time, perioperative analgesic and sedation need, postoperative pain scores, additional analgesic need, hospitalization and 24th-hour recovery scores will be evaluated.

Enrollment

60 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Partial Hip Arthroplasty
  • American Society of Anesthesiologists (ASA) physical status I-III,
  • Patients aged ≥ 65 years

Exclusion criteria

  • Contraindication for central or peripheral blocks,
  • Cognitive Dysfunction,
  • History of chronic opioid use,
  • Previous hip surgery,
  • Serious organ dysfunction,
  • Allergy to any drug used in the study,
  • Body mass index (BMI) ≥30,
  • Infection in the area to be treated,
  • Refusal to participate in the study

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Group PreS
Active Comparator group
Description:
The block will be applied in the preoperative period
Treatment:
Drug: Bupivacain (preoperative)
Drug: Bupivacaine-fentanyl
Group PostS
Active Comparator group
Description:
The block will be applied in the postoperative period
Treatment:
Drug: Bupivacain (Postoperative)
Drug: Bupivacaine-fentanyl

Trial contacts and locations

1

Loading...

Central trial contact

Ergun Mendes

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems